{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:08:18Z","timestamp":1787162898844,"version":"build-2736575974"},"reference-count":81,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.biopsych.2014.11.024","type":"journal-article","created":{"date-parts":[[2014,12,16]],"date-time":"2014-12-16T13:00:42Z","timestamp":1418734842000},"page":"117-126","source":"Crossref","is-referenced-by-count":45,"title":["Elevated Monoamine Oxidase-A Distribution Volume in Borderline Personality Disorder Is Associated With Severity Across Mood Symptoms, Suicidality, and Cognition"],"prefix":"10.1016","volume":"79","author":[{"given":"Nathan J.","family":"Kolla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Chiuccariello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan A.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Houle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Links","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Michael","family":"Bagby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley","family":"McMain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charis","family":"Kellow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalpa","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskevi V.","family":"Rekkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvercha","family":"Pasricha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey H.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2014.11.024_bib1","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1741-7015-11-126","article-title":"Toward the future of psychiatric diagnosis: The seven pillars of RDoC","volume":"11","author":"Cuthbert","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.biopsych.2014.11.024_bib2","doi-asserted-by":"crossref","first-page":"10923","DOI":"10.1073\/pnas.0601515103","article-title":"Monoamine oxidase A and repressor R1 are involved in apoptotic signaling pathway","volume":"103","author":"Ou","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2014.11.024_bib3","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrn1883","article-title":"The therapeutic potential of monoamine oxidase inhibitors","volume":"7","author":"Youdim","year":"2006","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.biopsych.2014.11.024_bib4","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1001\/archpsyc.63.11.1209","article-title":"Elevated monoamine oxidase A levels in the brain: An explanation for the monoamine imbalance of major depression","volume":"63","author":"Meyer","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2014.11.024_bib5","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/archgenpsychiatry.2009.156","article-title":"Brain monoamine oxidase A binding in major depressive disorder: Relationship to selective serotonin reuptake inhibitor treatment, recovery, and recurrence","volume":"66","author":"Meyer","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2014.11.024_bib6","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/archgenpsychiatry.2011.82","article-title":"Monoamine oxidase A binding in the prefrontal and anterior cingulate cortices during acute withdrawal from heavy cigarette smoking","volume":"68","author":"Bacher","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2014.11.024_bib7","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1001\/archgenpsychiatry.2010.32","article-title":"Elevated brain monoamine oxidase A binding in the early postpartum period","volume":"67","author":"Sacher","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2014.11.024_bib8","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1523\/JNEUROSCI.12-05-01977.1992","article-title":"Quantitative enzyme radioautography with 3H-Ro 41-1049 and 3H-Ro 19-6327 in vitro: Localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs, and human brain","volume":"12","author":"Saura","year":"1992","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2014.11.024_bib9","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/sj.jcbfm.9600197","article-title":"Positron emission tomography quantification of [11C]-harmine binding to monoamine oxidase-A in the human brain","volume":"26","author":"Ginovart","year":"2006","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2014.11.024_bib10","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.1073\/pnas.0710626105","article-title":"Structure of human monoamine oxidase A at 2.2-A resolution: The control of opening the entry for substrates\/inhibitors","volume":"105","author":"Son","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2014.11.024_bib11","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1001\/archpsyc.58.6.590","article-title":"The prevalence of personality disorders in a community sample","volume":"58","author":"Torgersen","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2014.11.024_bib12","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1521\/pedi.15.4.358.19181","article-title":"Are the interpersonal and identity disturbances in the borderline personality disorder criteria linked to the traits of affective instability and impulsivity?","volume":"15","author":"Koenigsberg","year":"2001","journal-title":"J Pers Disord"},{"key":"10.1016\/j.biopsych.2014.11.024_bib13","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1521\/pedi.2007.21.6.603","article-title":"The role of affective instability and impulsivity in predicting future BPD features","volume":"21","author":"Tragesser","year":"2007","journal-title":"J Pers Disord"},{"key":"10.1016\/j.biopsych.2014.11.024_bib14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/10673229809000330","article-title":"The pain of being borderline: Dysphoric states specific to borderline personality disorder","volume":"6","author":"Zanarini","year":"1998","journal-title":"Harv Rev Psychiatry"},{"key":"10.1016\/j.biopsych.2014.11.024_bib15","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1017\/S0033291702006657","article-title":"Neurocognitive deficits in decision-making and planning of patients with DSM-III-R borderline personality disorder","volume":"32","author":"Bazanis","year":"2002","journal-title":"Psychol Med"},{"key":"10.1016\/j.biopsych.2014.11.024_bib16","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1176\/ajp.2006.163.5.822","article-title":"Predictors of 2-year outcome for patients with borderline personality disorder","volume":"163","author":"Gunderson","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2014.11.024_bib17","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1017\/S1092852900014772","article-title":"Borderline personality disorder and traits in veterans: Psychiatric comorbidity, healthcare utilization, and quality of life along a continuum of severity","volume":"11","author":"Black","year":"2006","journal-title":"CNS Spectr"},{"key":"10.1016\/j.biopsych.2014.11.024_bib18","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.biopsych.2006.10.028","article-title":"Exaggerated affect-modulated startle during unpleasant stimuli in borderline personality disorder","volume":"62","author":"Hazlett","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2014.11.024_bib19","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.biopsych.2008.04.020","article-title":"The case for shifting borderline personality disorder to Axis I","volume":"64","author":"New","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2014.11.024_bib20","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0893-133X(98)00111-0","article-title":"d,l-fenfluramine response in impulsive personality disorder assessed with [18F]fluorodeoxyglucose positron emission tomography","volume":"20","author":"Siever","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2014.11.024_bib21","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/archpsyc.59.7.621","article-title":"Blunted prefrontal cortical 18fluorodeoxyglucose positron emission tomography response to meta-chlorophenylpiperazine in impulsive aggression","volume":"59","author":"New","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2014.11.024_bib22","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0006-3223(99)00202-4","article-title":"A fenfluramine-activated FDG-PET study of borderline personality disorder","volume":"47","author":"Soloff","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2014.11.024_bib23","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1176\/appi.ajp.158.5.775","article-title":"Brain regional alpha-[11C]methyl-L-tryptophan trapping in impulsive subjects with borderline personality disorder","volume":"158","author":"Leyton","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2014.11.024_bib24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/npp.1994.3","article-title":"Positron-emission tomography and personality disorders","volume":"10","author":"Goyer","year":"1994","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2014.11.024_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.biopsych.2012.07.014","article-title":"Neural correlates of negative emotionality in borderline personality disorder: An activation-likelihood-estimation meta-analysis","volume":"73","author":"Ruocco","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2014.11.024_bib26","doi-asserted-by":"crossref","first-page":"24195","DOI":"10.1074\/jbc.M112.373936","article-title":"Mechanistic role for a novel glucocorticoid-KLF11 (TIEG2) protein pathway in stress-induced monoamine oxidase A expression","volume":"287","author":"Grunewald","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopsych.2014.11.024_bib27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0304-3940(01)02495-8","article-title":"Repeated experience of social defeats increases serotonin transporter and monoamine oxidase A mRNA levels in raphe nuclei of male mice","volume":"321","author":"Filipenko","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.biopsych.2014.11.024_bib28","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.cell.2011.10.054","article-title":"SIRT1 activates MAO-A in the brain to mediate anxiety and exploratory drive","volume":"147","author":"Libert","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.biopsych.2014.11.024_bib29","doi-asserted-by":"crossref","first-page":"12940","DOI":"10.1523\/JNEUROSCI.5717-12.2013","article-title":"Rines E3 ubiquitin ligase regulates MAO-A levels and emotional responses","volume":"33","author":"Kabayama","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2014.11.024_bib30","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1080\/00223891.2010.513287","article-title":"Affect dysregulation in individuals with borderline personality disorder: Persistence and interpersonal triggers","volume":"92","author":"Sadikaj","year":"2010","journal-title":"J Pers Assess"},{"key":"10.1016\/j.biopsych.2014.11.024_bib31","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/00005053-200210000-00006","article-title":"Affect regulation in women with borderline personality disorder traits","volume":"190","author":"Yen","year":"2002","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.biopsych.2014.11.024_bib32","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/35037739","article-title":"Apoptosis in the nervous system","volume":"407","author":"Yuan","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2014.11.024_bib33","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.comppsych.2008.01.007","article-title":"Estimating the prevalence of borderline personality disorder in psychiatric outpatients using a two-phase procedure","volume":"49","author":"Korzekwa","year":"2008","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.biopsych.2014.11.024_bib34","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1001\/jamapsychiatry.2014.250","article-title":"Greater monoamine oxidase a binding in perimenopausal age as measured with carbon 11-labeled harmine positron emission tomography","volume":"71","author":"Rekkas","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.biopsych.2014.11.024_bib35","series-title":"Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II).","author":"First","year":"1997"},{"key":"10.1016\/j.biopsych.2014.11.024_bib36","series-title":"Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I\/P), Version 2.","author":"First","year":"2002"},{"key":"10.1016\/j.biopsych.2014.11.024_bib37","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1176\/ajp.155.12.1733","article-title":"Axis I comorbidity of borderline personality disorder","volume":"155","author":"Zanarini","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2014.11.024_bib38","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0197-0186(90)90046-V","article-title":"Selective inhibition of MAO-A in serotonergic synaptosomes by two amphetamine metabolites, p-hydroxyamphetamine and p-hydroxynorephedrine","volume":"17","author":"Arai","year":"1990","journal-title":"Neurochem Int"},{"key":"10.1016\/j.biopsych.2014.11.024_bib39","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/npp.2013.297","article-title":"Elevated monoamine oxidase A binding during major depressive episodes is associated with greater severity and reversed neurovegetative symptoms","volume":"39","author":"Chiuccariello","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2014.11.024_bib40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pscychresns.2006.01.011","article-title":"An automated method for the extraction of regional data from PET images","volume":"147","author":"Rusjan","year":"2006","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2014.11.024_bib41","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/nn1944","article-title":"Targeting abnormal neural circuits in mood and anxiety disorders: From the laboratory to the clinic","volume":"10","author":"Ressler","year":"2007","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.biopsych.2014.11.024_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pscychresns.2010.04.012","article-title":"3-D cytoarchitectonic parcellation of human orbitofrontal cortex correlation with postmortem MRI","volume":"183","author":"Uylings","year":"2010","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2014.11.024_bib43","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/jcbfm.2013.19","article-title":"Distribution of monoamine oxidase proteins in human brain: Implications for brain imaging studies","volume":"33","author":"Tong","year":"2013","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2014.11.024_bib44","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1124\/jpet.102.046953","article-title":"Mapping the cerebral monoamine oxidase type A: Positron emission tomography characterization of the reversible selective inhibitor [11C]befloxatone","volume":"305","author":"Bottlaender","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2014.11.024_bib45","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/jcbfm.1990.127","article-title":"Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(\u2212)-cocaine PET studies in human subjects","volume":"10","author":"Logan","year":"1990","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2014.11.024_bib46","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.biopsych.2014.11.024_bib47","first-page":"S44","article-title":"Development of neuropharmacologically based behavioral assessments of impulsive aggressive behavior","volume":"3","author":"Coccaro","year":"1991","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.biopsych.2014.11.024_bib48","series-title":"WAIS-R Manual","author":"Wechsler","year":"1981"},{"key":"10.1016\/j.biopsych.2014.11.024_bib49","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1076\/clin.12.1.43.1726","article-title":"Hopkins Verbal Learning Test\u2013Revised: Normative data and analysis of inter-form and test-retest reliability","volume":"12","author":"Benedict","year":"1998","journal-title":"Clin Neuropsychol"},{"key":"10.1016\/j.biopsych.2014.11.024_bib50","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1037\/0022-006X.47.2.343","article-title":"Assessment of suicidal intention: The Scale for Suicide Ideation","volume":"47","author":"Beck","year":"1979","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/j.biopsych.2014.11.024_bib51","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1","article-title":"Factor structure of the Barratt impulsiveness scale","volume":"51","author":"Patton","year":"1995","journal-title":"J Clin Psychol"},{"key":"10.1016\/j.biopsych.2014.11.024_bib52","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1037\/0022-3514.63.3.452","article-title":"The aggression questionnaire","volume":"63","author":"Buss","year":"1992","journal-title":"J Pers Soc Psychol"},{"key":"10.1016\/j.biopsych.2014.11.024_bib53","series-title":"Professional Manual for the State-Trait Anger Expression Inventory-2 (STAXI-2)","author":"Spielberger","year":"1999"},{"key":"10.1016\/j.biopsych.2014.11.024_bib54","doi-asserted-by":"crossref","first-page":"8591","DOI":"10.1074\/jbc.M510926200","article-title":"Parkin suppresses the expression of monoamine oxidases","volume":"281","author":"Jiang","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopsych.2014.11.024_bib55","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.brainres.2010.11.020","article-title":"Up-regulation of the isoenzymes MAO-A and MAO-B in the human basal ganglia and pons in Huntington\u02bcs disease revealed by quantitative enzyme radioautography","volume":"1370","author":"Richards","year":"2011","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2014.11.024_bib56","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF02260906","article-title":"Brain gamma-aminobutyrate aminotransferase (GABA-T) and monoamine oxidase (MAO) in patients with Alzheimer\u02bcs disease","volume":"4","author":"Sherif","year":"1992","journal-title":"J Neural Transm Park Dis Dement Sect"},{"key":"10.1016\/j.biopsych.2014.11.024_bib57","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1001\/archneur.1991.00530190064017","article-title":"Alterations in brain monoamine oxidase activity in aging, Alzheimer\u02bcs disease, and Pick\u02bcs disease","volume":"48","author":"Sparks","year":"1991","journal-title":"Arch Neurol"},{"key":"10.1016\/j.biopsych.2014.11.024_bib58","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0304-3940(02)00307-5","article-title":"Increased monoamine oxidase messenger RNA expression levels in frontal cortex of Alzheimer\u02bcs disease patients","volume":"326","author":"Emilsson","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.biopsych.2014.11.024_bib59","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/archgenpsychiatry.2011.37","article-title":"Ten-year course of borderline personality disorder: Psychopathology and function from the Collaborative Longitudinal Personality Disorders study","volume":"68","author":"Gunderson","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2014.11.024_bib60","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.4088\/JCP.v66n1121d","article-title":"Initial evidence of the beneficial effects of glutamate-modulating agents in the treatment of self-injurious behavior associated with borderline personality disorder","volume":"66","author":"Pittenger","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2014.11.024_bib61","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1001\/archpsyc.1988.01800260015002","article-title":"Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine","volume":"45","author":"Cowdry","year":"1988","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2014.11.024_bib62","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1001\/archpsyc.1993.01820170055007","article-title":"Efficacy of phenelzine and haloperidol in borderline personality disorder","volume":"50","author":"Soloff","year":"1993","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2014.11.024_bib63","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1001\/archgenpsychiatry.2010.93","article-title":"Correlation of glutamate levels in the anterior cingulate cortex with self-reported impulsivity in patients with borderline personality disorder and healthy controls","volume":"67","author":"Hoerst","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2014.11.024_bib64","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.biopsych.2006.10.022","article-title":"5HT2A receptor binding is increased in borderline personality disorder","volume":"62","author":"Soloff","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2014.11.024_bib65","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1176\/appi.ajp.160.1.90","article-title":"Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm","volume":"160","author":"Meyer","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2014.11.024_bib66","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.pscychresns.2014.03.008","article-title":"Effects of serotonin-2A receptor binding and gender on personality traits and suicidal behavior in borderline personality disorder","volume":"222","author":"Soloff","year":"2014","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2014.11.024_bib67","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1176\/appi.ajp.2010.09091348","article-title":"Dysregulation of regional endogenous opioid function in borderline personality disorder","volume":"167","author":"Prossin","year":"2010","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2014.11.024_bib68","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.euroneuro.2005.09.006","article-title":"alpha-[11C]Methyl-L-tryptophan trapping in the orbital and ventral medial prefrontal cortex of suicide attempters","volume":"16","author":"Leyton","year":"2006","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2014.11.024_bib69","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1038\/sj.npp.1301641","article-title":"Lower phosphoinositide 3-kinase (PI 3-kinase) activity and differential expression levels of selective catalytic and regulatory PI 3-kinase subunit isoforms in prefrontal cortex and hippocampus of suicide subjects","volume":"33","author":"Dwivedi","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2014.11.024_bib70","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1038\/npp.2011.105","article-title":"The reduction of R1, a novel repressor protein for monoamine oxidase A, in major depressive disorder","volume":"36","author":"Johnson","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2014.11.024_bib71","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jad.2014.02.010","article-title":"Apoptosis-related proteins and proliferation markers in the orbitofrontal cortex in major depressive disorder","volume":"158","author":"Miguel-Hidalgo","year":"2014","journal-title":"J Affect Disord"},{"key":"10.1016\/j.biopsych.2014.11.024_bib72","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.nbd.2009.11.010","article-title":"Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients","volume":"37","author":"Kim","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.biopsych.2014.11.024_bib73","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1176\/appi.ajp.163.1.20","article-title":"Borderline personality disorder and suicidality","volume":"163","author":"Oldham","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2014.11.024_bib74","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1038\/npp.2011.151","article-title":"Functional biomarkers of depression: Diagnosis, treatment, and pathophysiology","volume":"36","author":"Schmidt","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2014.11.024_bib75","series-title":"Targeting MAO-A as a Biomarker for MDD","author":"Meyer","year":"2012"},{"key":"10.1016\/j.biopsych.2014.11.024_bib76","doi-asserted-by":"crossref","first-page":"14208","DOI":"10.1021\/ja2057506","article-title":"Design of chemical shift-switching 19F magnetic resonance imaging probe for specific detection of human monoamine oxidase A","volume":"133","author":"Yamaguchi","year":"2011","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.biopsych.2014.11.024_bib77","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1212\/WNL.0b013e318259e1c5","article-title":"Hippocampal abnormalities and memory deficits in Parkinson disease: A multimodal imaging study","volume":"78","author":"Carlesimo","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2014.11.024_bib78","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.neuroimage.2008.07.022","article-title":"Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer\u02bcs disease","volume":"43","author":"Shin","year":"2008","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2014.11.024_bib79","first-page":"75","article-title":"Methodological considerations treatment trials for persons personality disorder","volume":"22","author":"Zanarini","year":"2010","journal-title":"Ann Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2014.11.024_bib80","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1521\/pedi.17.3.233.22147","article-title":"Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD): A continuous measure of DSM-IV borderline psychopathology","volume":"17","author":"Zanarini","year":"2003","journal-title":"J Pers Disord"},{"key":"10.1016\/j.biopsych.2014.11.024_bib81","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1521\/pedi.17.1.45.24053","article-title":"Reliability and validity of the borderline personality disorder severity index","volume":"17","author":"Arntz","year":"2003","journal-title":"J Pers Disord"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322314009871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322314009871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T10:01:17Z","timestamp":1566122477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322314009871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":81,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0006322314009871"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2014.11.024","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}